Clinical Trial Update: SCD-HeFT 10 Year Follow-up

View source ↗

Summary

This report provides the 10-year follow-up of the SCD-HeFT trial, a heart failure study evaluating strategies to prevent sudden cardiac death.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Cardiomyopathy
• Non-ischemic Cardiomyopathy
• Sudden Cardiac Death

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: Seattle Institute for Cardiac Research | Conditions: Left Ventricular Systolic Dysfunction, Congestive Heart Failure | Status: UNKNOWN